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Articles

International standards for fetal growth based on serial
ultrasound measurements: the Fetal Growth Longitudinal
Study of the INTERGROWTH-21st Project
Aris T Papageorghiou, Eric O Ohuma, Douglas G Altman, Tullia Todros, Leila Cheikh Ismail, Ann Lambert, Yasmin A Jaffer, Enrico Bertino,
Michael G Gravett, Manorama Purwar, J Alison Noble, Ruyan Pang, Cesar G Victora, Fernando C Barros, Maria Carvalho, Laurent J Salomon,
Zulfiqar A Bhutta*, Stephen H Kennedy*, José Villar*, for the International Fetal and Newborn Growth Consortium for the 21st Century
(INTERGROWTH-21st)†

Summary

Background In 2006, WHO produced international growth standards for infants and children up to age 5 years on the
basis of recommendations from a WHO expert committee. Using the same methods and conceptual approach, the
Fetal Growth Longitudinal Study (FGLS), part of the INTERGROWTH-21st Project, aimed to develop international
growth and size standards for fetuses.
Methods The multicentre, population-based FGLS assessed fetal growth in geographically defined urban populations
in eight countries, in which most of the health and nutritional needs of mothers were met and adequate antenatal
care was provided. We used ultrasound to take fetal anthropometric measurements prospectively from 14 weeks and
0 days of gestation until birth in a cohort of women with adequate health and nutritional status who were at low risk
of intrauterine growth restriction. All women had a reliable estimate of gestational age confirmed by ultrasound
measurement of fetal crown–rump length in the first trimester. The five primary ultrasound measures of fetal
growth—head circumference, biparietal diameter, occipitofrontal diameter, abdominal circumference, and femur
length—were obtained every 5 weeks (within 1 week either side) from 14 weeks to 42 weeks of gestation. The best
fitting curves for the five measures were selected using second-degree fractional polynomials and further modelled in
a multilevel framework to account for the longitudinal design of the study.
Findings We screened 13 108 women commencing antenatal care at less than 14 weeks and 0 days of gestation, of
whom 4607 (35%) were eligible. 4321 (94%) eligible women had pregnancies without major complications and
delivered live singletons without congenital malformations (the analysis population). We documented very low
maternal and perinatal mortality and morbidity, confirming that the participants were at low risk of adverse outcomes.
For each of the five fetal growth measures, the mean differences between the observed and smoothed centiles for the
3rd, 50th, and 97th centiles, respectively, were small: 2·25 mm (SD 3·0), 0·02 mm (3·0), and –2·69 mm (3·2) for
head circumference; 0·83 mm (0·9), –0·05 mm (0·8), and –0·84 mm (1·0) for biparietal diameter; 0·63 mm (1·2),
0·04 mm (1·1), and –1·05 mm (1·3) for occipitofrontal diameter; 2·99 mm (3·1), 0·25 mm (3·2), and –4·22 mm
(3·7) for abdominal circumference; and 0·62 mm (0·8), 0·03 mm (0·8), and –0·65 mm (0·8) for femur length. We
calculated the 3rd, 5th 10th, 50th, 90th, 95th and 97th centile curves according to gestational age for these ultrasound
measures, representing the international standards for fetal growth.
Interpretation We recommend these international fetal growth standards for the clinical interpretation of routinely
taken ultrasound measurements and for comparisons across populations.
Funding Bill & Melinda Gates Foundation.

Introduction
Screening for disturbances in fetal growth is one of the
main purposes of antenatal care. None of the biomarkers
assessed so far can accurately predict fetal growth
restriction;1 therefore, screening relies on routine
measurement of uterine fundal height, complemented
by ultrasound measurement of fetal size in women with
pregnancy complications or with a relevant history or
clinical evidence of fetal growth restriction.
Despite the widespread use of ultrasound worldwide,
concerns have been expressed about the low detection
rates of abnormal fetal growth in routine practice,2,3 even
www.thelancet.com Vol 384 September 6, 2014

when used mostly in high-risk subpopulations. However,
these observations should be interpreted with caution in
view of the large number of locally derived reference
charts available4 and the absence of suitable international
standards similar to the standards used for monitoring
infant growth.5 Additionally, large variation is seen in the
cutoff points (eg, 3rd, 5th, or 10th centile) used to
establish whether fetal growth is abnormal, even within
the same population or region.4 The use of such a range
of charts and cutoff points4,6 in clinical decision making
about fetal growth patterns inevitably leads to diagnostic
confusion, difficulties comparing outcomes across
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populations, and unnecessary anxiety for mothers and
their families.
International standards are urgently needed because,
unlike for the neonatal period, none are available to
enable fetal growth to be monitored as recommended
by WHO.7 The aim of the Fetal Growth Longitudinal
Study (FGLS)—part of the International Fetal and
Newborn Growth Consortium for the 21st Century
(INTERGROWTH-21st) Project—was to construct such
standards for fetal growth, adopting the same approach
and methods as the WHO Multicentre Growth
Reference Study (MGRS)8 by studying a cohort of
healthy, well nourished, pregnant women from
eight geographically diverse populations who were at
low risk of adverse maternal and perinatal outcomes.9,10

Methods

Study design and participants

For the INTERGROWTH-21st
website see www.
intergrowth21.org
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INTERGROWTH-21st is a multicentre, multiethnic,
population-based project done between April 27, 2009,
and March 2, 2014, in eight sites in eight countries:
Pelotas, Brazil; Turin, Italy; Muscat, Oman; Oxford, UK;
Seattle, WA, USA; Shunyi County, a suburban district of
the Beijing municipality, China; the central area of the
city of Nagpur (Central Nagpur), Maharashtra, India; and
the Parklands suburb of Nairobi, Kenya.9 The
INTERGROWTH-21st Project’s main aim was to study
growth, health, nutrition and neurodevelopment from
less than 14 weeks and 0 days of gestation to 2 years of
age, using the same conceptual framework as the WHO
MGRS,8 so as to produce prescriptive growth standards to
complement the existing WHO Child Growth Standards,5
and to develop a new phenotypic classification of the fetal
growth restriction and preterm birth syndromes.
FGLS is one of the three main studies of the
INTERGROWTH-21st Project, which has been described
in detail elsewhere.9 Briefly, the populations that
contributed participants to the project were first selected at
the geographical level and then at the individual level
within each study site. At the population level, we identified
an urban area (a complete city or county, or part of a city
with clear political or geographical limits) where most
deliveries occurred in health facilities. The areas had to be
located at an altitude of 1600 m or lower and women
receiving antenatal care had to plan to deliver in these
facilities or in a similar hospital located in the same
geographical area. Furthermore, the area had to be free or
have low levels of major, known, non-microbiological
contamination such as pollution, domestic smoke due to
tobacco smoking or cooking, radiation, or any other toxic
substances.11 At each of the eight study sites, we selected all
facilities providing antenatal and intrapartum care where
more than 80% of deliveries in those urban areas occurred.
At each study site we recruited women with the
characteristics required for FGLS—ie, women with no
clinically relevant obstetric, gynaecological, or medical
history who initiated antenatal care before 14 weeks of

gestation (measured by menstrual dates) and met the
entry criteria of optimal health, nutrition, education, and
socioeconomic status. A detailed description of the entry
criteria and definitions has been published previously.9
For example, adequate nutritional status was defined in
the first trimester according to maternal height (≥153 cm),
body-mass index (BMI; ≥18·5 and <30 kg/m²), and
haemoglobin concentration (≥110 g/L), and whether the
mother was receiving treatment for anaemia or following
any special diets—eg, vegetarian with no animal
products. This resulted in a group of educated, affluent,
clinically healthy women, with adequate nutritional
status, who by definition were at low risk of fetal growth
restriction and preterm birth.
The INTERGROWTH-21st Project was approved by the
Oxfordshire Research Ethics Committee “C” (reference:
08/H0606/139), the research ethics committees of the
individual participating institutions, and the corres
ponding regional health authorities where the project
was implemented. Participants provided written consent
to be involved in the study.

Procedures
The last menstrual period (LMP) was used to calculate
gestational age provided that the LMP date was certain;
the woman had a regular 24–32 day menstrual cycle; she
had not been using hormonal contraception or
breastfeeding in the preceding 2 months; and any
discrepancy between the gestational ages based on LMP
and crown–rump length (CRL), measured by ultrasound
between 9 weeks and 0 days and 13 weeks and 6 days after
the LMP, was 7 days or less, using the formula described
by Robinson and Fleming.12 To ensure that CRL measures
were interpreted consistently, the Robinson and Fleming
formula was loaded into all the study ultrasound
machines; whenever another machine had to be used
locally for CRL measurement, a conversion table extracted
from the same formula was provided. The CRL technique
was also standardised across sites and all
ultrasonographers were trained uniformly.13
We scanned women every 5 weeks (within 1 week
either side) after the initial dating scan, so that the
possible ranges after the dating scan were 14–18, 19–23,
24–28, 29–33, 34–38, and 39–42 weeks of gestation. At
each visit, fetal head circumference, biparietal diameter,
occipitofrontal diameter, abdominal circumference, and
femur length were measured three times from
three separately obtained ultrasound images of each
structure. The detailed measurement protocol and the
unique standardisation procedures have been reported
elsewhere,14 and all documentation, protocols, data
collection forms, and electronic transfer strategies are
freely available on the INTERGROWTH-21st website.
Briefly, head measurements were taken in an axial view
at the level of the thalami, with an angle of insonation as
close as possible to 90°. The head had to be oval in shape,
symmetrical, centrally positioned, and filling at least 30%
www.thelancet.com Vol 384 September 6, 2014
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of the monitor. The midline echo (representing the falx
cerebri) had to be broken anteriorly, at a third of its length,
by the cavum septi pellucidi. The thalami had to be located
symmetrically on either side of the midline. Callipers
were then placed on the outer border of the parietal bones
(outer to outer) at the widest or longest part of the skull for
the biparietal diameter and occipitofrontal diameter,
respectively; the head circumference was measured using
the ellipse facility on the outer border of the skull.
The measurements of the abdomen were taken in a
cross-sectional view of the fetal abdomen as close as
possible to circular, with the umbilical vein in the anterior
third of the abdomen (at the level of the portal sinus),
with the stomach bubble visible. The operator was
instructed to avoid applying too much pressure with the
transducer, which can distort the circular shape of the
fetal abdomen. The abdomen had to fill at least 30% of
the monitor screen, preferably, and the spine had to be at
either a 3 o’clock or 9 o’clock position to avoid internal
shadowing; the kidneys and bladder had not to be visible.
For the measurements, the contour of the ellipse was
placed on the outer border of the abdomen.
Recognising that the head and abdomen are elliptical
in shape, in addition to measurements of head
circumference and abdominal circumference obtained
using the ellipse facility of the ultrasound machine, head
circumference and abdominal circumference were also
estimated from the lengths of the two directly measured
diameters (major and minor axes). Because no explicit
(closed form) formula exists to calculate the
circumference of an ellipse from the diameters, common
approximations are used, based on the formula for a
circle. These approximations tend to be more accurate
when the two diameters are similar, especially when the
ratio of biparietal diameter to occipitofrontal diameter is
about 1; however, when this ratio is less than 0·8 it can
lead to bias. Therefore, we calculated head circumference
and abdominal circumference using an exact formula
derived from the elliptical integral (appendix).
Finally, the femur length was measured using a
longitudinal view of the fetal thigh closest to the probe
and with the femur as close as possible to the horizontal
plane. The angle of insonation of the ultrasound beam
was about 90°, with the full length of the bone visualised,
unobscured by shadowing from adjacent bony parts, and
the femur had to fill at least 30% of the monitor screen.
The intersection of the callipers was placed on the outer
borders of the edges of the femoral diaphysis (outer to
outer) ensuring clear femoral edges; ultrasound artefacts
of the femoral edges such as the proximal trochanter or
pointed femoral spurs were not included in the
measurement (detailed methods and a graphical display
of how the bone structures are localised are available on
the INTERGROWTH-21st website).
To reduce expected value bias, all measurements taken
at or after 14 weeks and 0 days of gestation were not
visible on the screen to the ultrasonographer, which was
www.thelancet.com Vol 384 September 6, 2014

achieved for the INTERGROWTH-21st Project by specially
adapting the ultrasound machine used at all sites (Philips
HD-9 [Philips Ultrasound, Bothell, WA, USA] with
curvilinear abdominal transducers C5-2, C6-3, V7-3).14 All
ultrasound data were submitted electronically to the
study’s database. After each set of measurements,
ultrasonographers scored the quality of their images on
the basis of standard image-scoring criteria.15,16 Images
that did not score the maximum amount of points were
repeated until the best possible score was achieved. The
training, standardisation, and quality-control methods
used across all sites are described in detail elsewhere.15 In
brief, ultrasonographers were recruited on the basis of
their technical experience, motivation, reliability, and
ability to speak the local language or languages. They
underwent rigorous training, consisting of acquisition of
theoretical knowledge and familiarity with the study
protocol, ultrasound operations manual, ultrasound
machine, data collection, and quality-control measures.
Centralised hands-on training and initial standardisation
were also done.17 Additionally, site-specific standardisation
was done at regular intervals by the ultrasound
quality-control unit to ensure proper use of the ultrasound
equipment, calibration, and adherence to the protocol. A
quality-control system was implemented throughout the
study with two main objectives: assessment of the
distributions of the three blinded measurements for each
fetal biometric measure at every scan and construction of
cumulative sum charts; and assessment of the quality of a
random 10% sample of all ultrasound images by the
centralised ultrasound quality-control unit using a
validated scoring system, and remeasurement of these
images.15 Only after three measurements of each structure
were recorded were the average values revealed to the
operator for clinical purposes.
All documentation used in the INTERGROWTH-21st
Project was tested locally and introduced into the
specially developed, online electronic data entry, cleaning,
and management system developed by MedSciNet UK
(London, UK). Data were entered locally directly onto the
web-based system.18 During data cleaning, we excluded
14 head circumference, six biparietal diameter,
two occipitofrontal diameter, 14 abdominal circum
ference, and seven femur length measurements because
they were regarded as implausible on the basis of all
sites’ gestational age distribution or were more than
5 SDs of all sites’ gestational age-specific mean.

See Online for appendix

Statistical analysis
The sample size was based on pragmatic and statistical
considerations; the latter focused on the precision and
accuracy of one extreme centile—ie, the 3rd or 97th
centile, and regression-based reference limits.19,20 We
have shown that a sample of 4000 women would obtain
precision of 0·03 SD at the 3rd or 97th centile. Further
details on the precision obtained at the 5th or 10th
centiles by sample size (ranging from 500 to 6000) were
871
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included in a table in a previous publication.21 Our target
was a sample of, on average, 500 pregnant women per
study site, after excluding complicated pregnancies and
those lost to follow-up. This sample size is larger than
most previous longitudinal studies and was considered
feasible and adequate to explore site-specific differences
or subgroups of about 10% of the whole study if needed.
We expected that, overall, less than 3% of participants
would be lost to follow-up, and that another 3% would
be excluded (using criteria decided a priori) from the
study population because of fetal deaths or congenital
abnormalities. We also planned to exclude mothers
diagnosed with very severe medical disorders (eg,
cancer or HIV) during the index pregnancy, those with
severe unanticipated pregnancy-related disorders
needing hospital admission (eg, eclampsia or severe
pre-eclampsia), and those identified during pregnancy
who no longer fulfilled all the entry criteria (eg, women
who started smoking during pregnancy or had an
episode of malaria). The decision to pool the data from
all the study sites to construct the fetal growth standards
was based on the detailed analyses done using the
strategy that was recommended in the WHO MGRS;
the results are described in detail elsewhere.10 The
statistical methods used to construct the fetal standards
from this pooled sample were based on the
recommendations of Altman and Chitty22 and Royston
and Altman,23 complemented by recent scientific
literature reviews24,25 and our systematic review of the
methods used in previous ultrasound studies aimed at
creating references of fetal size.26 Our overall aim was to
produce centiles that change smoothly with age and
maximise simplicity without compromising model fit.
We explored the following statistical methods: mean and
SD method using fractional polynomials;27 Cole’s lambda
(λ), mu (µ), and sigma (σ) (LMS) method,28–30 which
estimates three age-specific parameters (the median [µ],
coefficient of variation [σ], and a Box-Cox power
transformation at each gestational age to remove skewness
[λ], thereby making the data roughly normally distributed);
the LMST31 (ie, lambda, mu, sigma, assuming Box-Cox
t distribution) method, which assumes a shifted and scaled
(truncated) t distribution to take account of skewness and
leptokurtosis; the LMSP32 (ie, lambda, mu, sigma,
assuming Box-Cox power exponential distribution)
method, which assumes a Box-Cox power exponential
distribution to take account of skewness, platykurtosis,
and leptokurtosis; and multi-level models33,34 to account for
repeat measurements. Furthermore, to present the curves,
we assessed three smoothing techniques: fractional
polynomials,27 cubic splines,35 and penalised splines.36
After comparing results from the various approaches,
we found no evidence to support a non-normal
distribution for a specific gestational age. Thus, more
complex methods allowing for skewness and kurtosis
were not needed and the following methods were
chosen. The best fitting powers for the median head
872

circumference, biparietal diameter, occipitofrontal
diameter, abdominal circumference, and femur length
were provided by second-degree fractional polynomials
and further modelled in a multilevel framework to
account for the longitudinal design of the study. The
data structure is composed of three levels—ie,
measurements within occasions within participants. We
thus fitted a three-level hierarchical model using the
runmlwin package in Stata.34 To obtain an equation for
the SD, we modelled the resulting variance components
from the multilevel model that accounts for the
between-participant and within-participant correlations
using fractional polynomials. The SD was modelled on
the log scale to stabilise variance.
Goodness of fit incorporated visual inspection of overall
model fit by comparing empirical centiles (calculated per
completed week of gestation—eg, 38 weeks of gestation is
equal to 38 weeks and 0 days to 38 weeks and 6 days of
gestation) to the fitted centiles, using quantile-quantile
(q-q) plot of the residuals, plots of residuals versus fitted
values, and the distribution of fitted Z scores across
gestational ages. Adjusting for correlated data within
fetuses has a well known effect of making fitted centiles
slightly narrower by reducing random error;37,38 therefore,
we would expect the fitted centiles to be slightly narrower
than empirical ones. All analyses were done in R statistical
software39 using the Generalised Additive Models for
Location, Scale and Shape (GAMLSS) framework40,41 and
Stata, version 11.2, software.
Tables containing mean and SD, centile values, and
Z scores by gestational age, expressed in completed weeks
of gestation (as recommended by WHO International
Statistical Classification of Diseases and Related Health
Problems 10th Revision), as well as printable charts will
be available free on the INTERGROWTH-21st website. A
tool to calculate the individual centiles and Z scores by
gestational age (in exact weeks and days) will also be
available free on the same website by December, 2014.

Role of the funding source
The funders had no role in the study design, data
collection, data analysis, data interpretation, or writing of
the report. JV, ATP, EOO, FCB, DGA, CGV and SHK had
access to the full raw dataset. The corresponding author
had full access to all of the data and the final responsibility
to submit for publication.

Results
We screened 13 108 pregnant women attending the
study clinics at less than 14 weeks and 0 days of
gestation within the project’s defined geographical
areas, of whom 4607 (35%) met the eligibility criteria,
provided consent, and were enrolled (figure 1). The
most common reasons for ineligibility were low
maternal height (1022 [12%] of 8501 ineligible patients),
BMI 30 or higher (1009 [12%]), and maternal age
younger than 18 years or older than 35 years (915 [11%]).
www.thelancet.com Vol 384 September 6, 2014
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The contribution of each site to the total study
population ranged from 311 (7%) of 4607 in the USA to
640 (14%) in the UK. A detailed description of each
site’s population and their characteristics have been
presented before.9,10 36 (<1%) women who developed
severe disorders during pregnancy or took up smoking
or used drugs were excluded, and 71 (2%) were lost to
follow-up or withdrew consent. 4422 (96%) women
delivered a live singleton, of whom 4321 (98%) were
born without congenital malformations; their
longitudinal fetal growth data were used to construct
the fetal standards reported here.
A detailed description of the environmental
characteristics and working conditions in each
geographical area have been presented elsewhere.11 The
results of a survey using a data collection form specifically
developed for the project showed that most women were
not exposed to environmental hazards (eg, pollution,
domestic smoke due to tobacco smoking or cooking,
radiation, or any other toxic substances) that could affect
pregnancy outcomes; housing conditions were as
expected for relatively affluent populations in these
communities in terms of size, water, sanitation, and
construction characteristics.11

13 108 women interviewed

The baseline characteristics of the study cohort across
the eight sites were very similar, which was expected
because women were selected from the underlying
low-risk populations using the same clinical and
demographic criteria.10 Table 1 shows the pregnancy and
perinatal events for the complete cohort, which
confirmed their status as healthy, well nourished women
at low risk of impaired fetal growth.
The median number of ultrasound scans (excluding the
dating scan) in all women was 5·0 (range 1–7; mean 4·9
[SD 0·8]) and 3976 (92%) women had four or more scans;
of these 3976 women, the mean number of ultrasound
scans was 5·0 (SD 0·6; range 4–7), suggesting that
participants adhered well to the protocol. 17 261 (85%) of
the 20 313 ultrasound scans were done within the expected
gestational age window of the protocol (ranging from
2060 [76%] of 2707 in India to 2803 [93%] of 3006 in Oman).
The gestational age-specific observed and smoothed
centiles for head circumference, biparietal diameter,
occipitofrontal diameter, abdominal circumference, and
Pregnancies
(n=4321)
Maternal age, years

28·4 (3·9)

Maternal height, cm

162·2 (5·8)

Maternal weight, kg

61·3 (9·1)

Paternal height, cm

174·4 (7·3)

Body-mass index, kg/m²
8501 women ineligible at
screening or by ultrasound

11·8 (1·4)

Years of formal education, years

15·0 (2·8)

Haemoglobin level at <15 weeks, g/L
4607 women enrolled in FGLS

71 lost to follow-up or
withdrew consent
36 excluded:
29 severe maternal
disorders
6 smoking
1 recreational drugs

4204 (97%)

Nulliparous

2955 (68%)

Pre-eclampsia

31 (<1%)

Pyelonephritis

16 (<1%)

Any sexually transmitted infection
PPROM (<37 weeks)
Caesarean section
NICU admission >1 day

78 miscarriages, terminations,
and stillbirths

4321 livebirths without
congenital malformation
included in analysis

101 livebirths with congenital
malformation*

Figure 1: Fetal Growth Longitudinal Study (FGLS) flow chart
*Congenital malformations diagnosed by ultrasound during pregnancy or at
birth by clinical examination.

www.thelancet.com Vol 384 September 6, 2014

3 (<1%)
2868 (66%)
80 (2%)
1541 (36%)
240 (6%)

Preterm (<37 weeks)

195 (5%)

Preterm and spontaneous onset of labour

126 (3%)

Term LBW (<2500 g; ≥37 weeks)

128 (3%)

Neonatal mortality

7 (<1%)

Male sex

2149 (50%)

Exclusive breastfeeding at discharge

3786 (88%)

Mother admitted to intensive care unit
4422 livebirths

125 (11)

Married or cohabiting

Spontaneous initiation of labour

4500 women with pregnancy
and delivery information

23·3 (3·0)

Gestational age at first visit, weeks

17 (<1%)

Birthweight (≥37 weeks), kg

3·3 (0·4)

Birth length (≥37 weeks), cm

49·4 (1·9)

Birth head circumference (≥37 weeks), cm

33·9 (1·3)

Data are mean (SD) or number (%). Maternal baseline characteristics were
measured at less than 14 weeks of gestation. PPROM=preterm prelabour rupture
of membranes. NICU=neonatal intensive care unit. LBW=low birthweight.

Table 1: Baseline characteristics and perinatal events of the Fetal Growth
Longitudinal Study
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D
400
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350
Abdominal circumference (mm)

Occipitofrontal diameter (mm)

60

20

140

100

80

60

40

300
250
200
150
100

20
0

70

30

50
0

80

50
0

14 16 18 20 22 24 26 28 30 32 34 36 38 40
Gestational age (weeks)

0

14 16 18 20 22 24 26 28 30 32 34 36 38 40
Gestational age (weeks)

0

E
85
75

Femur length (mm)

65
55
45
35
25
15
5
0

Figure 2: Fitted 3rd, 50th, and 97th smoothed centile curves of fetal measurements
Fitted 3rd (bottom dashed line), 50th (middle dashed line), and 97th (top dashed line) smoothed centile curves for fetal head circumference (A), fetal biparietal
diameter (B), fetal occipitofrontal diameter (C), fetal abdominal circumference (D), and fetal femur length (E) measured by ultrasound according to gestational age.
Open red circles show empirical values for each week of gestation and open grey circles show actual observations.
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Figure 3: 3rd, 10th, 50th, 90th and 97th smoothed centile curves
Fetal head circumference (A), fetal biparietal diameter (B), fetal occipitofrontal diameter (C), fetal abdominal circumference (D), and fetal femur length (E) measured
by ultrasound according to gestational age.
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femur length are presented in figure 2. Similarities
between smoothed centile curves (3rd, 50th, and 97th
centiles) and observed values were assessed by
gestational age-specific comparisons. The comparisons
show excellent agreement between the smoothed and
empirical centiles.
Overall, the mean differences between smoothed and
observed centiles for the 3rd, 50th, and 97th centiles,
respectively, were small: 2·25 mm (SD 3·0), 0·02 mm
(3·0), and –2·69 mm (3·2) for head circumference
(figure 2A); 0·83 mm (0·9), –0·05 mm (0·8), and
–0·84 mm (1·0) for biparietal diameter (figure 2B);
0·63 mm (1·2), 0·04 mm (1·1), and –1·05 mm (1·3) for
occipitofrontal diameter (figure 2C); 2·99 mm (3·1),
0·25 mm (3·2), and –4·22 mm (3·7) for abdominal
circumference (figure 2D); and 0·62 mm (0·8),
0·03 mm (0·8), and –0·65 mm (0·8) for femur length
(figure 2E).
The 3rd, 5th, 10th, 50th, 90th, 95th, and 97th fitted
centile curves for head circumference, biparietal
diameter, occipitofrontal diameter, femur length, and
abdominal circumference according to gestational age,
which represent the international standards for fetal
growth, are presented in figure 3. The corresponding
equations for the mean and SD from the multilevel
regression models for each measure are presented in
table 2, allowing for calculations by readers of any
desired centiles according to gestational age in exact
weeks. For example, centiles can be calculated as
mean ± Z × SD, where Z is –1·88, –1·645, –1·28, 0, 1·28,
1·645, and 1·88 for the 3rd, 5th, 10th, 50th, 90th, 95th,
and 97th centiles, respectively. The actual values for
these centiles according to gestational age are presented
in the appendix.

Regression equation
Head circumference
Mean
SD

−28·2849 + 1·69267 × GA² − 0·397485 × GA² × log (GA)
1·98735 + 0·0136772 × GA³ − 0·00726264 × GA³ × log (GA) + 0·000976253 × GA³ × log (GA)²

Biparietal diameter
Mean
SD

5·60878 + 0·158369 × GA² − 0·00256379 × GA³
exp (0·101242 + 0·00150557 × GA³ − 0·000771535 × GA³ × log (GA) + 0·0000999638 × GA³ × log (GA)²)

Occipitofrontal diameter
Mean

−12·4097 + 0·626342 × GA² − 0·148075 × GA² × log (GA)

SD

exp (−0·880034 + 0·0631165 × GA² − 0·0317136 × GA² × log (GA) + 0·00408302 × GA² × log (GA)²)

Abdominal circumference
Mean
SD

−81·3243 + 11·6772 × GA − 0·000561865 × GA³
−4·36302 + 0·121445 × GA² − 0·0130256 × GA³ + 0·00282143 × GA³ × log (GA)

Femur length
Mean

−39·9616 + 4·32298 × GA − 0·0380156 × GA²

SD

exp (0·605843 − 42·0014 × GA–² + 0·00000917972 × GA³)

All log are natural logarithms. GA=exact gestational age.

Table 2: Equations for the estimation of the mean and SD (in mm) of each fetal biometry measurement
according to exact gestational age (in weeks)
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Discussion
To describe optimal fetal growth for singleton
pregnancies, the INTERGROWTH-21st Project used a
prescriptive approach42 to select a population of healthy,
well nourished pregnant women and their fetuses and
newborn babies, following the recommendation of the
special 1995 WHO Expert Committee43 and implemented
by the WHO MGRS for infants and children.7 This meant
studying a cohort of prospectively enrolled women whose
risk of adverse maternal and perinatal outcomes
(including fetal growth restriction) was low according to
their individual clinical profiles and the socioeconomic
and demographic characteristics of the underlying
eight geographically diverse populations.
From this population, we have generated the first
international standards (as opposed to references) for
fetal growth using the complete FGLS sample of 4321 live
singletons without congenital malformations, whose
healthy status has been confirmed by close follow-up of
the pregnancies, assessment of the neonates, and in
accordance with examination of their growth, nutrition,
and gross motor development at age 1 year.
Remarkably, at birth and age 1 year, the infants included
in the international fetal growth standards presented here
were very similar to those enrolled in the WHO MGRS,
whose data were used to construct the infant and child
growth standards that have now been adopted by more
than 140 countries. For example, the mean birth length at
more than 37 weeks and 0 days of gestation in the WHO
MGRS was 49·5 cm (SD 1·9), compared to 49·4 cm (1·9)
in the INTERGROWTH-21st cohort, and the mean
birthweight in the WHO MGRS was 3·3 kg (0·5), which
was virtually identical to ours 3·3 kg (0·4). Moreover, very
reassuringly, at age 1 year, the FGLS cohort was on the
49th and 52nd centiles for length and the 49th and 50th
centiles for head circumference (for boys and girls,
respectively) of the WHO Child Growth Standards.
Therefore, the international fetal growth standards
presented here contribute some crucial components to
the care of pregnant women and their children: a unique
set of clinical tools for use across all health-care systems
to diagnose fetal growth restriction uniformly and
monitor growth from early pregnancy, through the
neonatal period to age 5 years, founded on the same
conceptual and methodological approach and age-specific
cutoff points.
We believe these standards, as opposed to the several
locally produced references in use worldwide,4 have the
potential to improve pregnancy outcomes,44 not least
because at present the diagnosis of fetal growth
restriction is made at different levels of care, even within
the same regions or countries, using different fetal
growth charts and cutoff points—ie, fetuses can be
classified as growth restricted in one part of a city or
country and of healthy size in another. This leads to
inaccuracy in diagnosis and ultimately unnecessary, or
an absence of, appropriate interventions. Additionally,
www.thelancet.com Vol 384 September 6, 2014
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use of fetal growth standards derived from a healthy
population reduces the risk of underdiagnosing fetal
growth restriction, which can occur when the fetus is
monitored against references that include high-risk
mothers (panel).
The existing fetal growth references have some major
limitations, which were identified in a systematic review.4
They include retrospective design; use of routinely
obtained measurements; suboptimal pregnancy dating
strategies; absence of prospective ultrasound quality
control, standardisation, and calibration of equipment;
hospital-based sampling; absence of sampling from a
healthy, well nourished, underlying population; and no
blinding of measurements.4 In view of these limitations
and the reference nature of their design (ie, they are related
to a given place and time), the identification of fetuses with
growth restriction is, not surprisingly, problematic.
Additionally, the choice of reference chart to be used is
often based on local preference, or simply on the chart that
is loaded into the ultrasound machine software. However,
the choice has major clinical implications. For example,
the proportion of fetuses classified as having a biparietal
diameter below the 5th centile at 20–24 weeks of gestation
ranged from 6·6% to 23·7% when using three different
popular ultrasound references.46
Our study9 aimed to avoid these limitations.4 It was truly
prospective, and we used a population-based sampling
strategy that initially selected geographical regions where
a substantial proportion of women are healthy, well
nourished, educated, and at low risk of fetal growth
restriction, from which, in a second step, we identified
pregnant women for FGLS, on the basis of several
individual clinical and demographic characteristics. The
ultrasound measurements were taken specifically for the
purpose of constructing international standards and
the method was rigorous and implemented across all
study sites: we standardised the measurement of fetal
size using centrally trained staff; each study site used the
same specially adapted ultrasound equipment to allow
blinding of measurements; more than one measurement
for each biometric variable was taken at each scan to
reduce error; and we developed a novel quality-control
strategy for all ultrasound measurements, including
assessment of intraobserver and interobserver variability
at all sites and continual independent image review and
scoring at a central location where all images were stored
for independent re-measuring.14,15 Finally, the appropriate
statistical methods were used to analyse our dataset of
repeated measurements; hence, we are in effect
describing true growth.
Unfortunately, not all eligible women from the
underlying low-risk population were enrolled because of
the logistical constraints of having only one dedicated
ultrasound machine at each site for the study. Eligible
women were recruited consecutively at each antenatal
clinic in the geographical areas up to a weekly limit
(about six women per week per site) to avoid
www.thelancet.com Vol 384 September 6, 2014

Panel: Research in context
Systematic review
Ultrasound is widely used worldwide to detect abnormal fetal growth, but its accuracy as
a test is dependent upon the reliability of the fetal size chart used. A systematic review
identified 83 observational studies, published from Jan 1, 1968, to Sept 30, 2011, whose
primary aim was to create such charts. We searched Medline, Embase, and CINAHL for
studies published in English. A list of search terms used has been published previously.4
We found 337 studies, which had substantial methodological heterogeneity, and none
met the WHO recommendations for monitoring fetal anthropometric measurements.7
The large number of charts available, the reference nature of their design (ie, they are
related to a given place and time), and the variation in the cutoff points used to define
abnormal growth, make it difficult in routine clinical practice to identify fetal growth
restriction (FGR). International standards are, therefore, urgently needed, in keeping with
those available for children from birth to age 5 years.5,44
Interpretation
From our cohort of healthy, well nourished pregnant women prospectively enrolled from
eight geographically diverse populations, and whose risk of adverse maternal and perinatal
outcomes (including FGR) was low, we have generated the first international standards for
fetal growth based on the primary ultrasound measures of head circumference, biparietal
diameter, occipitofrontal diameter, abdominal circumference, and femur length, according
to gestational age. Combined with our newborn standards,45 the new fetal standards are
for use worldwide to diagnose FGR uniformly and monitor growth from early pregnancy
through to the neonatal period. We recommend these tools for the interpretation of
routine ultrasound measurements and comparisons across populations.

overwhelming the capacity of the project’s ultrasound
research team. We believe that the risk of selection bias
was small, and comparisons show that the FGLS cohort
was very similar to the corresponding total population of
women with the same characteristics from which the
FGLS cohort was obtained.10
The inevitable and recurrent question related to the
implementation of international, prescriptive growth
standards (including ours) is whether or not they can be
generalised to all populations, considering that they
were generated, in our case, from only eight
geographically diverse study sites. The answer is that the
generalisability of anthropometric standards based on
a prescriptive approach and international sampling
frames of geographically and ethnically diverse
populations is supported by the uncertainty surrounding
the identification of functionally significant, common
genetic variants that are unique to ethnic groups in
quantitative, complex traits.47,48 Additionally, we used a
population-based sample of well nourished participants
at each of the INTERGROWTH-21st sites—ie, we
intentionally controlled for well documented adverse
environmental or socioeconomic conditions that are
universal constraints on fetal growth, thereby
considerably reducing a common cause for populationwide growth differences often observed in diverse
populations. Furthermore, the empirical data produced
from the same population showed the similarity from
early pregnancy to birth of all the fetal and newborn
skeletal measures across the study sites.10
877

Articles

Finally, the cumulative experience gained from
implementation in more than 140 countries of the WHO
MGRS standards, which were derived from the
prescriptive, international study of postnatal growth, and
whose design and methods were almost identical to the
INTERGROWTH-21st Project, further supports the
generalisability of our standards. International growth
standards can be regarded as close to universal as
possible and more accurate than other available methods.
We hope that these international fetal growth standards,
complementing our published standards for early fetal
linear size,49 in addition to our newborn standards,45 will
contribute to the recently launched Every Newborn
Action Plan that focuses on the “development of a
minimum perinatal dataset with standard metrics for
counting births, stillbirths, neonatal deaths, birthweight,
and gestational age”.50
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acknowledge—can vary according to where the
practitioner is working on different days of the week.7
The multicentre, population-based Fetal Longitudinal
Growth Study (FLGS) of the International Fetal and
Newborn Growth Consortium for the 21st Century
(INTERGROWTH-21st) Project cuts through the noise with a
clear signal. Led by researchers from around the world, this
study has followed the methods of the WHO Multicentre
Growth Reference Study,8 recruiting more than 4000
pregnant women from eight countries. Although differing
in ethnicity, these women were intentionally sampled
for their shared trait of being at low risk of pregnancy
complications attributable to malnutrition, obesity,
socioeconomic deprivation, or major environmental
pollution. A recent publication from this group came to the
conclusion that fetuses and newborn infants grow very
similarly in these eight different research settings.9
This information is especially valuable for the multi
cultural societies that now exist in many European,

See Articles page 869
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Those working with pregnant women know the
situation well: whether a particular unborn baby
is judged to be too small will partly depend on the
choice of fetal biometric charts used. Some charts can
increase the likelihood of finding a fetal measurement
below a threshold for smallness by fourfold or more.1
Inconsistent chart use and overestimation of fetal
smallness can result in cynicism, confusion, and anxiety
for pregnant women and their caregivers at all stages
of pregnancy. The stakes are especially high when
smallness of biometric measures alone raises a red flag
for aneuploidy, other genetic syndromes such as skeletal
dysplasia, or fetal developmental abnormalities such
as microcephaly. In later pregnancy, suspected fetal
smallness might trigger interventions such as induction
of labour and caesarean section, with consequent risks,
including iatrogenic prematurity. Human, pregnancy,
and financial costs are likely to follow.
However, to miss true fetal growth restriction is
equally serious because suboptimum birthweight is
associated with lifelong health disadvantages.2 Most
pertinent to maternity caregivers is that fetal growth
restriction is the single biggest risk factor for stillbirth.
The fourfold increase in stillbirth risk in the growthrestricted fetus is doubled again in those in whom fetal
growth restriction is undetected.3 An accepted universal
standard of fetal size and growth is urgently needed.
Robust methods for fetal biometric chart development
have been described since the 1990s,4,5 but many
frequently used charts do not adhere to these standards.6
Practitioners might not be able to identify and access
a methodologically superior chart easily, and instead
default to what is loaded onto their ultrasound machine
or follow institutional practices, which—clinicians
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North American, and Australasian countries, which
are characterised by high rates of immigration and
intermarriage. To expect all fetuses to have the same
growth potential irrespective of ethnic origin is simple
and fair: identification of ethnic origin might not be
straightforward in multicultural societies, and to adapt
fetal growth expectations for ethnic origin creates the
risk of generating an expectation of poorer perinatal
outcome.10 The latter can detract from efforts to improve
perinatal outcomes for vulnerable groups. Arguably,
the most important conclusion that can be drawn from
the INTERGROWTH-21st Consortium’s findings is that
recorded intercountry differences in fetal size and growth
are more indicative of deprivation than geographical
location. Acceptance of international growth standards
involves a change in theoretical approach and sets the
bar for universal aspirational targets of fetal growth.
In The Lancet, Aris Papageorghiou and colleagues11 for
the International Fetal and Newborn Growth Consortium
for the 21st Century (INTERGROWTH-21st) report FLGS
charts for fetal biparietal diameter, head circumference,
occipitofrontal diameter, abdominal circumference,
and femur length, which were obtained every 5 weeks
(within 1 week either side) from 14 weeks to 42 weeks of
gestation. These charts have been developed with great
care, including sonographer training, quality assurance,
attention to minimisation of bias, data management,
and statistical and ethical aspects, which have been
described previously.12 No issue was too small for
consideration. For example, questions such as whether
the biparietal diameter should be measured outer-toouter—as in the new FLGS charts—or outer-to-inner
were discussed with guideline writers, opinion leaders,
and experienced sonographers, with the final decision
favouring continuity with postnatal measurements.13
Of particular importance, Papageorghiou and
colleagues achieved a sample size of 4321, which is
sufficiently large to produce reliable extreme centiles
that are of clinical significance. The charts were not
artificially modified by post-hoc truncation to produce
a supernormal middle range of measurements such as
10th–90th centiles, but present aspirational standards
with valid extreme measurement values. The 3rd, 5th,
10th, 50th, 90th, 95th, and 97th centile curves were
calculated according to gestational age for each of the
five ultrasound measures, representing the international
standards for fetal growth. The mean differences between
836

the observed and smoothed centiles for the clinically
important 3rd and 97th centiles, respectively, were
small: 2·25 mm and –2·69 mm for head circumference;
0·83 mm and –0·84 mm for biparietal diameter; 0·63 mm
and –1·05 mm for occipitofrontal diameter; 2·99 mm and
–4·22 mm for abdominal circumference; and 0·62 mm
and –0·65 mm for femur length. To put these differences
into context, they are five-to-ten-times smaller than the
differences between varying charts.
We strongly encourage fetal medicine, obstetrics, and
midwifery professional bodies to adopt and endorse
consistent use of these high-quality, globally relevant
charts, which give the best available answer to how
unborn babies should be growing.
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